As reported by our previous studies, TAMs secreted CCL18 and induced breast cancer cell invasion and EMT through PITPNM3.[3, 9, 15] To explore the inhibitory effects of C8018‐7840 on TAMs‐conducted invasion, we first acquired TAMs. Here, CCL18 is linked to breast carcinoma.